To ascertain whether predischarge arteriography is beneficial in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin, the outcome of 197 patients in the Thrombolysis in Myocardial Infarction (TIMI) IIA study assigned to conservative management and routine predischarge coronary arteriography (routine catheterization group) was compared with the outcome of 1,461 patients from the TIMI lIB study assigned to conservative management without routine coronary arteriography unless ischemia recurred spontaneously or on predischarge exercise testing (selective catheterization group). The two groups were similar with regard to important baseline variables.
groups (routine catheterization group 73.1 %, selective catheterization group 61.3 %). During the 1st year after infarction, rehospitalization for cardiac reasons and the interim performance of coronary arteriography were more common in the selective catheterization group (37.9% versus 27.6%, p = 0.007 and 28.6% versus 11.6%, p < 0.001, respectively); however, the interim rates of death, nonfatal reinfarction and performance of coronary revascularization procedures were similar.
At the end of 1 year, coronary arteriography had been performed one or more times in 98.9% of the routine catheterization group and 59.4% of the selective catheterization group (p < 0.001), whereas death and nonfatal reinfarction had occurred in 10.2% versus 7.0% (p = 0.10) and 8.6% versus 9.0% (p = 0.87), respectively. Because the selective coronary arteriography policy exposes about 40% fewer patients to the small but finite risks and inconvenience of the procedure without compromising the 1 year survival or reinfarction rates, it seems to be an appropriate management strategy.
(J Am Coil CardioI1991; 17:1007-16) tion and premature death by identifying for subsequent mechanical revascularization subsets of patients with "high risk" coronary anatomy, such as those with left main or three vessel coronary artery disease or large zones of viable myocardium jeopardized by stenotic coronary arteries (3); and 3) the knowledge of coronary anatomy may allow more prompt institution of appropriately tailored therapy, shortening hospitalization and subsequent convalescence (4) and perhaps preventing cardiac readmissions. However, rather than routine postinfarction arteriography, some reports (5, 6) have advocated a more selective approach, targeting coronary arteriography to patients with a specific clinical indication such as recurrent ischemia, thus avoiding the risks and expense of the procedure in patients having no specific indication for it and helping to curb "reperfusion momentum" (7) , the tendency to revascularize all lesions visualized, regardless of significance.
The purpose of this report is to compare the outcome of the routine and selective predischarge arteriography strategies in two conservatively managed subgroups of patients entered into the Thrombolysis in Myocardial Infarction (TIMI) Phase II study. In one group, termed the routine catheterization group, predischarge coronary arteriography was mandated by protocol; whereas, in the other group, termed the selective catheterization group, predischarge arteriography was advised only for pressing clinical indications such as spontaneous or exercise-induced recurrent ischemia.
Methods
Study design and patients. The study group consisted of patients allocated to conservative management in the Thrombolysis in Myocardial Infarction (TIMI) I1A and lIB trials. Detailed descriptions of the design and findings of these trials have been previously published (8, 9) . Briefly, the primary objective of the TIMI II trials was to assess the role and timing of percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction treated with recombinant tissue-type plasminogen activator. In these trials, patients were randomized to either an invasive strategy in which coronary arteriography and angioplasty, if appropriate, were done early after rt-PA administration or to a conservative management strategy in which coronary arteriography was performed only for specific clinical indications such as recurrent ischemia. In the TIMI lIA trial, predischarge contrast left ventriculographic ejection fraction was the primary end point and therefore all patients, even those in the conservative management group, were required to undergo predischarge cardiac catheterization. In the larger TIMI lIB trial, the primary end point was the occurrence of death and reinfarction at 6 weeks after entry into the study; thus, predischarge cardiac catheterization was performed only if there were clinical indications.
The purpose of this report is to assess the role of predischarge coronary arteriography in patients initially managed with intravenous thrombolytic therapy without early coronary arteriography. Therefore, the present study focuses solely on the outcome of the parallel subsets of patients assigned to conservative management in the TIMI lIA trial (termed the routine catheterization group) and lIB trial (termed the selective catheterization group).
Patients were eligible for TIMI II if they were <76 years of age, had ischemic chest pain of dO min duration and ST elevation 2:0.1 m V in at least two contiguous electrocardiographic (ECG) leads, gave written informed consent, could have rt-PA therapy initiated within 4 h of onset of acute myocardial infarction symptoms and had none of the exclusion criteria shown in Table I .
The TIMI lIA patients were recruited between April II, 1986 and September 24, 1987 at seven hospitals with special interest and proficiency in immediate angioplasty for acute myocardial infarction. The TIMI lIB patients were recruited between April II, 1986 and June 30, 1988 at 43 additional hospitals. After termination of TIMI I1A recruitment in September 1987, the seven hospitals previously recruiting patients for the TIMI lIA trial began to recruit patients for the TIMI lIB trial. Thus, the routine catheterization group consisted of patients recruited exclusively from the 7 hospitals performing the TIMI IIA protocol whereas the selective catheterization group was composed of l) patients recruited from the 43 hospitals performing the TIMI liB protocol through September 24, 1987 , and 2) patients from the combined 50 hospitals performing the TIMI lIB protocol after September 24, 1987 . The Committee on Human Research at each participating hospital approved the study protocol before patient recruitment.
Administration of rt-PA and ancillary therapy. Patients received intravenous rt-PA (supplied by Genentech) over 6 h in a dose of 100 or 150 mg, as previously described (8, 9) . Before rt-P A administration, patients were prospectively classified by acute myocardial infarction "risk status" (8) . Immediately after initiation of rt-PA, heparin (5,000 U) was given as an intravenous bolus injection, followed by a 5 day intravenous heparin infusion with dosage titrated to maintain the activated partial thromboplastin time 1.5 to 2.0 times the upper limit of normal. Beginning on day 6, heparin (10,000 U every 12 h) was administered subcutaneously, continuing until the patient underwent a predischarge exercise test.
Aspirin was administered at a dose of 81 mg/day beginning on day I (235 patients) or day 2 (l, 132 patients) and then increased to 325 mg/day on day 6. On initial presentation, all patients received sublingual nitroglycerin, morphine and prophylactic intravenous lidocaine, unless contraindicated.
Ancillary nifedipine and metoprolol therapy differed between the routine catheterization and selective catheterization groups. Nifedipine (10 to 20 mg three times daily) was administered for 96 h to TIMI IIA patients undergoing angioplasty to prevent coronary spasm and was administered to the remaining IIA patients (including the routine catheterization group) in the same dosage to render them comparable. Prophylactic nifedipine was not utilized in the TIMI lIB protocol (selective catheterization group).
In the selective catheterization group, patients received metoprolol (50 to 100 mg twice daily) unless contraindicated, commencing on day 6 before exercise testing; as part of a substudy, 334 patients received metoprolol intravenously (:s15 mg) immediately after initiation of rt-PA and treatment with daily oral maintenance metoprolol (50 to 100 mg twice daily) was immediately begun. In the TIMI IIA protocol (routine catheterization group), metoprolol was administered only as oral maintenance therapy and was not initiated until day 8 to 10, after exercise testing and contrast left ventriCUlography, so that beta-adrenergic blockade would not influence the primary end point, ejection fraction.
Classification of events. Episodes of recurrent chest pain, ECG changes or an increase in cardiac enzymes were reviewed by an independent Mortality and Morbidity Classification Committee that used predetermined definitions to classify such events as definite myocardial infarction, recurrent ischemia or no event (10) .
Limited exercise testing. Patients underwent supine rest and bicycle exercise radionuclide ventriculography on day 8 to 10 after study entry to assess simultaneously left ventricular function and the clinical response to submaximal exercise. After in vivo red blood cell labeling with technetium-99m pertechnetate (11), equilibrium radionuclide ventriculography was performed at rest and then during 3 min stages of 200 and 400 kilopond m/min work load. The exercise test was terminated after two stages or if there was occurrence of one or more of the following: 1) heart rate of ~120 beats/min; 2) complex ventricular arrhythmias; 3) angina pectoris; 4) >20 mm Hg decrease in blood pressure; 5) exhaustion or marked dyspnea; or 6) ~2 mm ST segment depression 0.08 s after J point compared with the rest ECG. Radionuclide data on magnetic tape or 8 in. (20 cm) floppy disks were forwarded from each clinical center to the TIMI Radionuclide Core Laboratory for analysis.
Coronary arteriography. In the routine catheterization group after the radionuclide studies, coronary arteriograms in multiple standardized projections were obtained (along with contrast left ventriculograms) and forwarded to the TIMI Radiographic Core Laboratory for analysis. In the selective catheterization group, the protocol discouraged coronary arteriography unless the patient developed spontaneous recurrent ischemia or had evidence of ischemia on the exercise test.
Follow-up at 6 weeks and 1 year. Rest and exercise radionuclide ventriculography was repeated at 6 weeks (window 6 to 12 weeks). Exercise at 6 weeks was continued until a limiting symptom occurred or until age-predicted (220 beats/min minus age) maximal heart rate was achieved. At I year after study entry (window 12 to 18 months), a ROGERS ET AL.
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PREDISCHARGE CORONARY ARTERIOGRAPHY history of interim rehospitalizations, clinical events and procedures was elicited.
Statistical methods. For discrete data variables, comparisons between routine catheterization and selective catheterization in the proportions of patients having the given attribute were tested with the use of a chi-square test. For continuous data variables, comparisons between the groups were tested using a two-tailed Student's t test of mean values. Cumulative event rates were estimated by the product-limit (Kaplan-Meier) method (12) and comparisons in the event distributions over time between the routine and selective catheterization groups were made with use of the log-rank statistic. All analyses were performed with use of SAS programs (13) . Comparison between the routine and selective catheterization groups is not based on a comparison of randomized groups. To adjust for mUltiple testing and account for the fact that none of these analyses were for comparisons of randomized groups, p values between 0.01 and 0.001 provide some evidence of differences between the groups and p values <0.001 provide strong evidence of a difference.
Results
Baseline characteristics (Table 2) . Although patients were not randomized between the routine and selective catheterization groups, their baseline characteristics were similar. A slight racial imbalance between the two groups was noted. The majority of the patients were categorized as "not low risk," primarily because of ECG changes of anterior acute myocardial infarction, history of prior myocardial infarction or advanced age. Chest pain was still ongoing in 88% of each group when recombinant tissue-type plasminogen activator (rt-PA) was initiated. The time interval between onset of pain to onset of rt-PA infusion was slightly but significantly longer (2.9 versus 2.6 h, p < 0.(01) in the routine catheterization group.
Clinical events during initial hospitalization (Table 3) . Clinical events suggesting a need for coronary arteriography occurred equally in the routine and selective catheterization groups. Specifically, the prevalence of chest pain persisting after the 6 h rt-PA infusion, recurrent chest pain, nonfatal reinfarction and other in-hospital hemodynamically important complications were similar between the two groups. Among patients undergoing exercise testing, there were more positive tests in those in the routine catheterization group, in whom beta-adrenergic blocker therapy was deferred until after testing.
Performance of coronary arteriography (Table 4) . Coronary arteriography was performed in 185 (94%) ofthe routine catheterization group and in 507 (35%) of the selective catheterization group (p < 0.(01). Of the 12 patients in the routine catheterization group not having predischarge arteriography, 9 died during the initial hospitalization and 3 refused the procedure. When performed, arteriography was done significantly earlier in patients in the selective cathe- In a hierarchical analysis of reasons for the performance of coronary arteriography (Fig. J) , the primary indication for the procedure in the selective catheterization group was recurrent ischemia (spontaneous ischemia, reinfarction or positive exercise test), occurring in 352 patients (24.1 % of the selective catheterization group). Other potential indications for arteriography such as heart failure, shock, ventricular septal rupture, mitral regurgitation, cardiac arrest, chest pain persisting after rt-PA infusion was completed, inadequate duration of exercise or failure to perform the exercise test accounted for 64 patients undergoing arteriography (4.4% of the selective catheterization group). Patient or physician preference dictated performance of coronary arteriography in 91 patients (6.2% of the selective catheterization group).
Coronary arteriographic findings (Table 4 ). The distribution of the number of major coronary arteries with stenosis ~60% differed between the routine and selective catheterization groups. Although there was a predominance of single vessel disease in both groups, there was more multivessel disease among those undergoing arteriography in the selective catheterization group. Left main coronary artery stenolACC Vol. 17 *Refers to complications occurring within 1st 10 days of hospitalization. All percents are crude event rates. tExercise tests were not performed in 44 patients in the routine catheterization group (of whom 13 died during the initial hospitalization) and 271 patients in the selective catheterization group (of whom 52 died during the initial hospitalization). tLocal clinic assessment of ischemic ST segment depression. EF = ejection fraction; other abbreviations as in Figure 2. sis was detected in a higher proportion of patients in the routine catheterization group, but ~60% stenosis of the left main coronary artery and total occlusion of the infarctrelated artery was found with equal frequency.
Complications of coronary arteriography and revascularization procedures (Table 5) . In both groups, catheterization-related complications were infrequent. In keeping with the conservative management strategy common to both the routine and selective catheterization groups, coronary artery revascularization procedures were performed infrequently during the initial hospitalization: angioplasty in 17% and 13% and bypass surgery in 10% and 9%, respectively. Angioplasty-related complications were infrequent in both groups; there were nonsignificant trends toward more angioplastyrelated myocardial infarction and emergency bypass surgery in the routine catheterization group. However, bypass surgery-related complications occurred with equal frequency in the two groups.
Radionuclide left ventriculography (Table 6 ). Both at hospital discharge and at 6 week follow-up study, the routine and selective catheterization groups had similar values for both global and segmental (infarct zone) ejection fraction.
In-hospital death and clinical events (Table 7) . During the initial hospitalization, death occurred about twice as often in the routine catheterization group as in the selective cathe- terization group (8% versus 4%, p = 0.013), but the frequency of reinfarction, death or nonfatal reinfarction and coronary artery revascularization procedures was similar.
The higher hospital mortality rate in the routine catheterization group (TIM! IIA hospitals) appeared to be related more to some as yet unidentified aspect of the TIMI IIA protocol Tables I and 2. than to the hospitals performing the TIMI IIA protocol or the earlier time frame in which the TIMI IIA protocol was performed. The hospital mortality rate for conservatively managed patients at the seven hospitals participating in the TIMl lIA trial was 8% (16 of 197) before September 24, 1987 and 3% (4 of 122) when these hospitals enrolled patients in the TIMl lIB trial. At the 43 original hospitals participating in the TIMI lIB trial, the hospital mortality rate for patients assigned to conservative management was 4% (39 of 880) before September 24, 1987 versus 4% (22 of 581) afterward. Among the 16 patients in the routine catheterization group and 61 in the selective catheterization group who died during the initial hospitalization, death was of cardiac origin in 81% and 77%, respectively; pump failure was a contributing factor in 69% and 68%, respectively, of the cardiacrelated deaths. Of the 16 patients in the routine catheterization group who died during the initial hospitalization, 7 (44%) had undergone coronary arteriography and 3 (19%) had undergone a revascularization procedure (angioplasty or bypass surgery, or both); in contrast, of the 61 patients in the selective catheterization group who died during the initial hospitalization, 14 (23%) had undergone coronary arteriography and 8 (13%) had undergone a revascularization procedure. Two of the three revascularization procedures in the routine catheterization group were complicated and possibly contributory to death, but in both patients, coronary arteriography and revascularization were prompted by the occurrence of spontaneous recurrent ischemia. Events after hospital discharge (Table 7) . Between initial hospital discharge and 1 year follow-up, death, nonfatal reinfarction and fatal or nonfatal reinfarction occurred with equal frequency in the routine and selective catheterization groups, but rehospitalization for cardiac reasons and the performance of coronary arteriography was significantly more common in the selective catheterization group (Fig. 2  and 3 ). Angina prompted rehospitalization in 23% of the selective catheterization group versus 12% of the routine catheterization group (p < 0.001). At 1 year follow-up, the cumulative mortality rate was 10% in the routine catheterization group compared with 7% in the selective catheterization group (p = 0.10) and the cumulative rates of reinfarction, death or nonfatal reinfarction were similar (Fig. 2) . Tables I and 2 . ------------------------------------------- -table  analyses) . There was a nonsignificant trend toward a higher mortality rate in the routine (solid lines) catheterization than in the selective (dashed lines) group, but the combined frequency of death and nonfatal reinfarction in the two groups was similar.
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The cumulative frequency of performing bypass surgery or angioplasty one or more times, alone or in combination, was similar in the two groups (Fig. 3) , but the cumulative performance rate of coronary arteriography remained significantly higher in the routine catheterization group compared with the selective catheterization group (99% versus 59%, p < 0.001). (14) at 1 year follow-up were similar between the two groups (Table 7) , most patients reporting no angina and the same activity status as before acute myocardial infarction.
Activity level and Canadian Cardiovascular Society angina classification

Discussion
The present study demonstrates that patients with acute myocardial infarction selected as candidates for thrombolytic therapy according to Thrombolysis in Myocardial Infarction (TIMI) II protocol guidelines and managed conservatively with recombinant tissue-type plasminogen activator (rt-PA), heparin and aspirin have a predominance of zero and one vessel disease on predischarge arteriography. Although the policy of selective rather than routine coronary arteriography after myocardial infarction for these patients was associated with a higher frequency of angina prompting readmission for coronary arteriography over the next year, cumulative mortality and reinfarction rates and frequency of late revascularization procedures were similar at I year after myocardial infarction. In this observational study, a higher Figure 3 . Cumulative frequency of rehospitalization, coronary arteriography and revascularization procedures. Although rehospitalization for cardiac reasons was more common in the selective catheterization (Cath) group (dashed lines) and the performance of coronary arteriography was overall more common in the routine catheterization group (solid lines), both groups had similar frequencies of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass graft (CABG) surgery. Days Following Study Entry initial in-hospital mortality rate-of unknown explanationwas noted in the group undergoing routine predischarge arteriography. However, it seems unlikely that the arteriography itself or invasive procedures that followed explained the higher mortality rate. Routine postinfarction arteriography. Patients surviving hospitalization for acute myocardial infarction are at increased risk of reinfarction and death during the subsequent year, especially if they have extensive multivessel coronary artery disease jeopardizing large zones of non infarcted myocardium (3, 15) . Patients with acute myocardial infarction given thrombolytic therapy in placebo-controlled trials (16) (17) (18) have had a higher rate of reinfarction than that of conventionally managed control patients, and thus it has been proposed (2) that all patients undergoing intravenous thrombolytic therapy should undergo diagnostic cardiac catheterization before hospital discharge.
Previous studies (19) (20) (21) (22) (23) (24) performed during the pre thrombolytic era demonstrated that predischarge coronary arteriography was associated with few complications and was generally accepted and often desired by patients and their physicians as a means of defining the coronary anatomic pattern responsible for the recent infarction, providing important prognostic insight and guiding recommendations for convalescence and return to work. A survey of cardiologists in 1987 (1) revealed that 86% were using coronary arteriography routinely after uncomplicated acute myocardial infarction treated with intravenous thrombolytic agents. However, despite the enthusiasm for routine predischarge coronary arteriography, controlled trial data to verify its benefits are lacking.
The present study confirms earlier reports (21) (22) (23) (24) of the safety of routine predischarge coronary arteriography. There were no deaths directly attributable to diagnostic arteriography. Furthermore, although 2 of the 16 hospital deaths in the routine catheterization group were possibly related to complications occurring during angioplasty, these deaths occurred in patients experiencing recurrent ischemia after myocardial infarction who would likely have undergone arteriography and revascularization had they been in the selective catheterization group.
Selective catheterization policy. Rather than subjecting all patients with recent myocardial infarction to routine predischarge cardiac catheterization, some reports (5,6) have recommended that coronary arteriography be reserved for patients having evidence of recurrent myocardial ischemia. It has been convincingly demonstrated (5) that patients at highest risk for death or recurrent ischemic events during the 1st year after infarction can be identified by noninvasive testing at the time of hospital discharge. The TIMI II trial is the first large scale study to implement routine predischarge exercise testing for risk stratification in survivors of acute myocardial infarction. The TIMI II trial results reported herein confirm that in patients undergoing this process of predischarge risk stratification, death and recurrent ischemic events during the 1st year after hospitalization for acute 
00-1 V
~2V
.3V Figure 4 . Number of vessels diseased. The proportion of patients having zero or one, two or three vessel disease (V) when predischarge coronary arteriography was performed within 4 weeks of myocardial infarction is shown. In contrast to the findings from four studies (15, 21, 22, 24) during the prethrombolytic era (left), a greater proportion of zero or one vessel disease was observed in the present study (right), which employed thrombolytic therapy, intravenous heparin and aspirin. In the prior studies, the definition for a "diseased vessel" was ~50% (15, 21, 24) or ~70% (22) stenosis, whereas in the present study, ~60% stenosis (by Core Laboratory assessment) was considered significant. myocardial infarction are no more frequent if coronary arteriography is performed selectively, primarily for recurrent ischemia, than if it is performed routinely. Coronary anatomy after infarction. The present study demonstrated a predominance of zero «60% stenosis) and one vessel disease among those undergoing predischarge coronary arteriography in marked contrast to earlier studies (15, 21, 22, 24) of predischarge coronary arteriography performed during the prethrombolytic era (Fig. 4) . Several factors may explain this observation. First, treatment with rt-PA, heparin and aspirin probably opened some infarctrelated arteries that otherwise would have remained occluded. Thus, in those patients in whom lysis was complete and residual atherosclerotic narrowing was not severe, the number of vessels classified as "diseased" may have been reduced by one. Second, in the prethrombolytic era, many studies of predischarge arteriography failed to obtain arteriograms for the majority of patients presenting with infarction, introducing a selection bias toward more symptomatic patients, perhaps those with more extensive coronary artery disease.
Finally and most important, patients in the present study are themselves a selected group of patients (Table 1) . To ensure optimal candidacy for thrombolytic therapy, the TIMI II trial excluded many subgroups expected to have a high prevalence of multivessel disease (for example, those with prior bypass surgery, prior angioplasty, age >75 years, severe hypertension, prior cerebrovascular disease and lack of ST elevation on admission ECG). These exclusions are the most likely explanation for the high prevalence of zero or one vessel disease in the present study and other recent reports of thrombolytic therapy (25, 26) and to some extent may explain why such patients do well after infarction.
Rehospitalizations. The selective catheterization strategy was associated with a higher frequency of readmissions for angina pectoris during the 1st year after myocardial infarction, and during these hospitalizations, more than twice as many patients in the selective group underwent coronary arteriography as did patients in the routine catheterization group during the same time interval. Surprisingly, however, the frequency of coronary revascularization procedures during these hospitalizations, as well as the cumulative frequency of all revascularization procedures through 1 year, were not significantly different between the two groups. This observation suggests that coronary anatomic patterns judged clinically to need revascularization can be detected with equal efficacy and safety by either the routine or the selective coronary arteriography strategy. The data further suggest that the "threshold" for readmitting patients with recurrent chest pain after infarction may be lower when coronary arteriography is not performed routinely during the initial hospitalization. The potential increased costs imposed by the excessive number of readmissions in the selective catheterization group will require further analysis. Cost data were not collected uniformly during TIMI II, but were analyzed at 3 of the 50 TIMI II hospitals (27) ; 1 year follow-up findings in these patients will be reported separately.
Study limitations. The TIMI II trial was not designed to compare the routine and selective catheterization strategies. The routine and selective catheterization groups analyzed in the present study represent two subgroups of patients enrolled in TIMI II according to identical entry criteria, but not randomized with respect to each other. Subtle differences in protocols, patient demographics, time to entry after onset of symptoms of infarction, variable duration of hospitalization and other unknown differences between these two noorandomized groups may have contributed to the observed differences (or lack of differences) in their outcome. It should be recalled that the two patient groups were for the most part enrolled at different hospitals and were managed according to slightly different ancillary therapy protocols. Early administration of a calcium channel antagonist was more prevalent in the routine catheterization group, whereas in the selective catheterization group, there was greater utilization of a beta-adrenergic blocker. These differences, and perhaps others not appreciated in this observational study, probably explain the difference in hospital survival between the two groups.
The results of our large observational study correspond almost exactly with those of a smaller recently reported trial (28) of 201 patients with acute myocardial infarction who were treated with rt-PA, heparin and aspirin and randomized to receive routine coronary arteriography and angioplasty 5 days later or to receive arteriography and angioplasty only if ischemia recurred. In that study (28) , similar to ours, coronary arteriography was performed in 95% of the first group and 37% of the second. A 10 month mortality rate of 8% and 4% (p = 0.15), respectively, was reported and a higher rate of readmission during the next year was observed in the group without predischarge coronary arteriography; however, there was no difference in left ventricular function or reinfarction rate.
Clinical implications. The present study illustrates that in patients with acute myocardial infarction selected and treated according to the criteria of the TIMI II study, a policy of coronary arteriography reserved for those with pressing clinical indications such as recurrent ischemia is acceptable and exposes the patients to no greater risk of death or reinfarction than a more aggressive policy of routine predischarge coronary arteriography. Patients managed according to the policy of selective coronary arteriography are more likely to experience angina, prompting repeat hospitalization for arteriography during the 1st year after myocardial infarction; the economic implications of these excess admissions will require further study. However, despite the performance of interim coronary arteriography in some patients, the policy of selective arteriography exposes about 40% fewer patients to the small but finite risks and inconvenience of coronary arteriography during the 1st year after myocardial infarction. In the absence of data showing that routine predischarge arteriography improves clinical outcome in patients after thrombolytic therapy for acute myocardial infarction, we believe that selective arteriography is the preferable policy.
